(Q80147524)
Statements
Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial (English)
Felix Zijlstra
Alexander Hirsch
Robin Nijveldt
Pieter A van der Vleuten
Bart J Biemond
Pieter A Doevendans
Albert C van Rossum
Jan G Tijssen
Jan J Piek
HEBE investigators
1 September 2006